Nephrology Doctors in Nebraska Medicare Details, Address, Contact
45 Nephrology doctors found. Showing 41 - 45
 Dr. Lindsay Jayne Gage, M.D. Internal Medicine - Nephrology Medicare: Medicare Enrolled Practice Location: 1111 N 102nd Ct Ste 200, Omaha, NE 68114 Phone: 402-502-2747 Fax: 402-502-2387 |
 Sunil Kumar Jagadesh, Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 7710 Mercy Rd Ste 426, Omaha, NE 68124 Phone: 402-343-8650 Fax: 402-343-8545 |
Dr. Mohamedanwar Moawia Noureldin Ghandour, MD Internal Medicine - Nephrology Medicare: Medicare Enrolled Practice Location: 7710 Mercy Rd Ste 426, Omaha, NE 68124 Phone: 402-343-8650 Fax: 402-343-8545 |
Clifford D Miles, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 988102 Nebraska Medical Ctr, Unmcp Provider Services, Omaha, NE 68198 Phone: 402-559-4015 Fax: 402-559-2093 |
Ruba M Sarsour, D.O. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3911 Avenue B Ste 1100, Scottsbluff, NE 69361 Phone: 308-630-2100 Fax: 308-630-2138 |
News Archive
New research shows that cancer patients can not intentionally postpone death to survive for significant personal events
Contrary to previous reports, new research shows that cancer patients can not intentionally postpone death to survive for significant personal events such as Christmas, Thanksgiving or a birthday, according to a study in the December 22/29 issue of JAMA.
Maintaining funding for global health programs will ensure success
"The ongoing budget negotiations in Washington will require many hard choices to be made in the coming weeks," and "[w]ith respect to global health programs, these decisions may mean, literally, the difference between life and death," Peter Chernin - chair and CEO of the Chernin Group, chair of Malaria No More, and a board member of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria – writes in an AlertNet opinion piece.
Resuscitation with colloids not recommended
Resuscitation with colloids does not appear to decrease the risk for death, and may even increase mortality, a comprehensive study of trial data reveals.
Exelixis announces regaining of rights to develop and commercialize XL184
Exelixis, Inc. today announced that it has regained full rights to develop and commercialize XL184. Exelixis and Bristol-Myers Squibb Company entered into a global development collaboration for XL184, the clinically most advanced MET inhibitor, in December 2008. Under the agreement, BMS and Exelixis had originally agreed to certain clinical development plans, and Exelixis maintained key rights regarding timing and funding of current and future clinical trials.
› Verified 1 days ago